OCUP - Ocuphire Pharma - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

OCUP is currently covered by 1 analysts with an average price target of $14.03. This is a potential upside of $12.9 (1141.59%) from yesterday's end of day stock price of $1.13.

Ocuphire Pharma's activity chart (see below) currently has 14 price targets and 20 ratings on display. The stock rating distribution of OCUP is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 10% with an average time for these price targets to be met of 0.2 days.

Highest price target for OCUP is $1, Lowest price target is $1.

Most recent stock forecast was given by JOHN NEWMAN from CANACCORD on 22-Oct-2024. First documented stock forecast 18-Nov-2020.

Best performing analysts who are covering OCUP - Ocuphire Pharma:

John Newman Kristen Kluska Jim Molloy Prakhar Agrawal Matthew Caufield

Currently out of the existing stock ratings of OCUP, 1 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

1 years 2 days ago
(22-Oct-2024)

0/2 (0%)

$20.62 (246.06%)

Buy

1 years 2 months 11 days ago
(13-Aug-2024)

0/2 (0%)

$15.84 (380.77%)

Buy

$17

$15.87 (1404.42%)

$22

2 years 2 months 11 days ago
(13-Aug-2023)

0/4 (0%)

$12.84 (308.65%)

Buy

$2.03

$-0.35 (-14.71%)

$25

3 years 5 months 6 days ago
(19-May-2022)

1/2 (50%)

$-0.01 (-0.49%)

1

Buy

$20

$18.87 (1669.91%)

$20

4 years 4 months 24 days ago
(31-May-2021)

0/2 (0%)

$15.21 (317.54%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is OCUP (Ocuphire Pharma) average time for price targets to be met?

On average it took 0.2 days on average for the stock forecasts to be realized with a an average price target met ratio 10

Which analyst has the current highest performing score on OCUP (Ocuphire Pharma) with a proven track record?

JOHN NEWMAN

Which analyst has the current lower performing score on OCUP (Ocuphire Pharma) with a proven track record?

MATTHEW CAUFIELD

Which analyst has the most public recommendations on OCUP (Ocuphire Pharma)?

John Newman works at CANACCORD and has 5 price targets and 4 ratings on OCUP

Which analyst is the currently most bullish on OCUP (Ocuphire Pharma)?

Prakhar Agrawal with highest potential upside - $18.87

Which analyst is the currently most reserved on OCUP (Ocuphire Pharma)?

Jim Molloy with lowest potential downside - -$0.35

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?